共 120 条
[21]
Riquet M(2023)Role of sentinel lymph node biopsy for skin cancer based on clinical studies Cancers 15 3291-761
[22]
Le Pimpec-Barthes F(2019)Systemic therapy for the treatment of endometrial cancer Expert Opin Pharmacother 20 2019-350
[23]
Danel C(2019)High-grade endometrial cancer-behaviour and outcomes at a tertiary cancer centre Indian J Surg Oncol 10 662-100
[24]
Sanuki JI(2021)Pembrolizumab in endometrial cancer: where we stand now Oncol Lett 22 821-2992
[25]
Uchida Y(2011)Developments in the systemic treatment of endometrial cancer Crit Rev Oncol Hematol 79 278-undefined
[26]
Uematsu T(2017)Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1-positive endometrial cancer: results from the KEYNOTE-028 study J Clin Oncol Off J Am Soc Clin Oncol 35 2535-undefined
[27]
Yamada Y(2022)Pembrolizumab in patients with microsatellite instability-high advanced endometrial cancer: results from the KEYNOTE-158 study J Clin Oncol Off J Am Soc Clin Oncol 40 752-undefined
[28]
Kasami M(2023)Biomarker-driven therapy in endometrial cancer Int J Gynecol Cancer 33 343-undefined
[29]
Foote RL(2022)Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001 Int J Gynecol Cancer 32 93-undefined
[30]
Schray MF(2020)Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer J Clin Oncol Off J Am Soc Clin Oncol 38 2981-undefined